These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3930145)

  • 21. Reversal of the growth inhibitory effect of alpha-difluoromethylornithine by putrescine but not by other divalent cations.
    Oredsson SM; Anehus S; Heby O
    Mol Cell Biochem; 1984 Sep; 64(2):163-72. PubMed ID: 6438490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion.
    Seidenfeld J; Komar KA
    Cancer Res; 1985 May; 45(5):2132-8. PubMed ID: 3921237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of ileal and colonic ornithine decarboxylase activity by alpha-difluoromethylornithine in rats: transient atrophic changes and loss of postresectional adaptive growth.
    Kingsnorth AN; Abu-Khalaf M; LaMuraglia GM; McCann PP; Diekema KA; Ross JS; Malt RA
    Surgery; 1986 Jun; 99(6):721-7. PubMed ID: 2424111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the irreversible ornithine decarboxylase inhibitor, alpha-difluoromethylornithine, aflatoxin B1, and choline deficiency on hepatocarcinogenesis.
    Sondergaard D; Taylor F; Newberne PM
    Toxicol Pathol; 1985; 13(1):36-49. PubMed ID: 2412277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
    Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
    Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl)dehydroornithine.
    Mamont PS; Danzin C; Kolb M; Gerhart F; Bey P; Sjoerdsma A
    Biochem Pharmacol; 1986 Jan; 35(2):159-65. PubMed ID: 3080004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
    Alhonen-Hongisto L; Levin VA; Marton LJ
    Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced cell death in skin flaps in rats treated with difluoromethylornithine.
    Gelman J; Bartolome JV; Jenkins S; Serafin D; Schanberg SM; Klitzman B
    FASEB J; 1987 Dec; 1(6):474-7. PubMed ID: 3119414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine.
    Takigawa M; Verma AK; Simsiman RC; Boutwell RK
    Biochem Biophys Res Commun; 1982 Apr; 105(3):969-76. PubMed ID: 6807316
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidermal keratinocytes actively maintain their intracellular polyamine levels.
    Roseeuw DI; Marcelo CL; Rhodes LM; Voorhees JJ
    Cell Tissue Kinet; 1983 Sep; 16(5):493-504. PubMed ID: 6192925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alpha-difluoromethylornithine on pancreatic growth induced by caerulein.
    Benrezzak O; Morisset J
    Regul Pept; 1984 Oct; 9(3):143-53. PubMed ID: 6084857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.
    Fozard JR; Part ML; Prakash NJ; Grove J
    Eur J Pharmacol; 1980 Aug; 65(4):379-91. PubMed ID: 6773783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociated regulation of growth and ornithine decarboxylase activity by estrogen in the rat uterus.
    Rorke EA; Katzenellenbogen BS
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1186-93. PubMed ID: 6433909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ornithine aminotransferase activity, tissue ornithine concentrations and polyamine metabolism.
    Seiler N; Daune G; Bolkenius FN; Knödgen B
    Int J Biochem; 1989; 21(4):425-32. PubMed ID: 2501116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DL-alpha Difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, blocks chick embryo development at gastrulation.
    Löwkvist B; Heby O; Emanuelsson H
    Acta Chem Scand B; 1980; 34(6):459-60. PubMed ID: 6781188
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of ornithine decarboxylase activity by small doses of alpha-difluoromethylornithine.
    Loprinzi CL; Verma AK
    Cancer Lett; 1985 Sep; 28(3):327-33. PubMed ID: 3931903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
    Slotkin TA; Persons D; Slepetis RJ; Taylor D; Bartolome J
    Teratology; 1984 Oct; 30(2):211-24. PubMed ID: 6208628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyamine depletion inhibits the differentiation of L6 myoblast cells.
    Erwin BG; Ewton DZ; Florini JR; Pegg AE
    Biochem Biophys Res Commun; 1983 Aug; 114(3):944-9. PubMed ID: 6412710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization of human tumor cells by alpha-difluoromethylornithine.
    Courdi A; Milano G; Bouclier M; Lalanne CM
    Int J Cancer; 1986 Jul; 38(1):103-7. PubMed ID: 3087889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.